房颤流行病与医疗费用

单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,房颤的患病率,(ATRIA,研究,),JAMA 2001; 2370,不同研究中房颤的患病率,J Cardiovasc Nurs 2004; 94,房颤患者的住院率,Circulation 2003; 711,美国房颤患病率的发展趋势,JAMA 2001; 2370,中国房颤的发病率,Int J Cardiol 2005; 283,中国,-,房颤的患病率,Crude prevalence 0.77%,Age-standardized prevalence 0.65%,male 0.66% ; female 0.63%,J Epidemiol 2008; 209,中国,-,房颤患者的年龄构成,Int J Cardiol 2005; 283,中国,-,房颤的病因以及相关发病因素,Int J Cardiol 2005; 283,中国,-,非瓣膜病房颤患者脑卒中发病率,Chin J Cardiol,2002;165,Incidence of Stroke (/year),%,中国,-,房颤,/,非房颤患者脑卒中的患病率,Stroke (n),Non-stroke (n),Total subjects (n),Prevalence of stroke (%),AF,29,195,224,12.95,Non-AF,657,28173,28855,2.28,Sum,686,28368,29079,2.36,J Epidemiol 2008; 209,房颤患者的抗栓治疗和脑卒中发生率,Treatment Group,Patients,Patients with stroke,Rate of stroke(%),Antiplatelet,4991,334,6.7,Anticoagulant,572,32,5.5,No antithrombotic,3062,741,24.2,Int J Cardiol 2005; 283,中国当前房颤的治疗情况,Anticoagulation,(%),Ablation (10,000),房颤年度医疗花费的构成,Europace 2008; 403,不同因素对房颤治疗价,/,效关系的影响,Pharmacoeconomics,2000; 317,房颤导管消融与药物治疗医疗费用的比较,PACE 2003; 292,US,UK,不同国家房颤医疗费用的构成,Am Heart J 2004;121,房颤医疗费用的构成,房颤消融前后对医疗资源占用的比较,JICE 2003; 59,J Cardiovasc Electrophysiol 2008; Epub,房颤导管消融与药物治疗费用的比较,Preablation examinations,:,CT,、,TEE,、,TTE,、,biochemical test,Catheter ablation,：,Abl catheter,、,Reference pad,、,Lasso catheter,Postablation medication,Warfarin,、,Amiodarone,中国,-,导管消融的费用,Total cost: 60,000-80,000 RMB,Thank you!,Atrial fibrillation,：,The Epidemic and Cost,Changsheng Ma, M.D.,Department of Cardiology,Beijing Anzhen Hospital, Capital Medical University,Beijing, P.R. China,Dem 13, 2008,Prevalence of Diagnosed AF(ATRIA study),JAMA 2001; 2370,Prevalence of AF in population-based studies,J Cardiovasc Nurs 2004; 94,Prevalence of hospitalizations for AF,Circulation 2003; 711,Projected Number of AF in U.S,JAMA 2001; 2370,Incidence of AF in China,Int J Cardiol 2005; 283,Prevalence of AF in China,Crude prevalence 0.77%,Age-standardized prevalence 0.65%,male 0.66% ; female 0.63%,J Epidemiol 2008; 209,Age distribution of patients with AF,Int J Cardiol 2005; 283,Causes and associated factors for AF,Int J Cardiol 2005; 283,Incidence of Stroke in patients with NVAF,Chin J Cardiol,2002;165,Incidence of Stroke (/year),%,Prevalence of stroke in AF/non-AF cohorts,Stroke (n),Non-stroke (n),Total subjects (n),Prevalence of stroke (%),AF,29,195,224,12.95,Non-AF,657,28173,28855,2.28,Sum,686,28368,29079,2.36,J Epidemiol 2008; 209,Antithrombotic treatment and stroke rate in AF,Treatment Group,Patients,Patients with stroke,Rate of stroke(%),Antiplatelet,4991,334,6.7,Anticoagulant,572,32,5.5,No antithrombotic,3062,741,24.2,Int J Cardiol 2005; 283,Current treatment of AF in China,Anticoagulation,(%),Ablation (10,000),Distribution of annual costs of AF,Europace 2008; 403,Influence of variables on cost/effectiveness of AF therapy,Pharmacoeconomics,2000; 317,Costs of Ablation vs Medication of AF,PACE 2003; 292,US,UK,Distribution of costs of care in AF,Distribution of costs of care in AF in the societal perspective,Am Heart J 2004;121,Comparison of healthcare resource utilization before and after ablation,JICE 2003; 59,J Cardiovasc Electrophysiol 2008; Epub,Costs of Ablation vs Medication of AF,Preablation examinations,:,CT,、,TEE,、,TTE,、,biochemical test,Catheter ablation,：,Abl catheter,、,Reference pad,、,Lasso catheter,Postablation medication,Warfarin,、,Amiodarone,Costs of AF Catheter ablation in China,Total cost: 60,000-80,000 RMB,Thank you!,